Skip to main content
Log in

Effects of apolipoproteins on dalargin transport across the blood-brain barrier

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Antinociceptive activity of dalargin (7.5 mg/kg) adsorbed on poly(butyl)cyanoacrylate nanoparticles with different coating was studied on outbred albino mice by the tail-flick test. Poly(butyl)cyanoacrylate nanoparticles without coating did not increase the antinociceptive activity of dalargin and hence, did not increase its transport across the blood-brain barrier. Poly(butyl)cyanoacrylate nanoparticles coated with apolipoprotein B, apolipoprotein E, and polysorbate 80 increased the transport of dalargin across the blood-brain barrier. Delivery of dalargin to the brain was most effective in case of using poly(butyl)cyanoacrylate nanoparticles with polysorbate 80 coating and subsequent supercoating with apolipoprotein E.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. Alyautdin, D. Gothier, V. Petrov, et al., Eur. J. Pharm. Biopharm., 41, 44–48 (1995).

    CAS  Google Scholar 

  2. R. Alyautdin, V. E. Petrov, K. Langer, et al., Pharm. Res., 14, 325–328 (1997).

    Article  PubMed  CAS  Google Scholar 

  3. D. J. Begley, J. Pharm. Pharmacol., 48, 136–146 (1996).

    PubMed  CAS  Google Scholar 

  4. H. Davson and M. Segal, Physiology of the CSF and Blood-Brain Barrier, Boca Raton (1996), pp. 1–192.

  5. B. Dehouck, M. P. Dehouck, J. C. Fruchart, and R. Cecchelli, J. Cell. Biol., 126, 465–473 (1994).

    Article  PubMed  CAS  Google Scholar 

  6. B. Dehouck, L. Fenart, M.-P. Dehouck, et al., Ibid., 138, 877–889 (1997).

    Article  PubMed  CAS  Google Scholar 

  7. L. Fenart, A. Casanova, B. Dehouck, et al., J. Pharmacol. Exp. Ther., 291, 1017–1022 (1999).

    PubMed  CAS  Google Scholar 

  8. J. Kreuter and R. Alyautdin, The Blood-Brain Barrier and Drug Delivery to the CNS, Eds. D. J. Begley et al., New York (2000), pp. 205–223.

  9. J. Kreuter, R. Alyautdin, D. A. Kharkevich, and A. A. Ivanov, Brain Res., 674, 171–174 (1995).

    Article  PubMed  CAS  Google Scholar 

  10. J. Kreuter, V. E. Petrov, D. A. Kharkevich, and R. Alyautdin, J. Control. Release, 49, 81–87 (1997).

    Article  CAS  Google Scholar 

  11. A. Minn, R. D. S. El-Bacha, C. Bayol-Denizot, et al., The Blood-Brain Barrier and Drug Delivery to the CNS, Eds. D. J. Begley et al., New York (2000), pp. 145–170.

  12. P. Ramge, R. E. Unger, B. Oltrogge, et al., Eur. J. Neurosci., 12, 1931–1940 (2000).

    Article  PubMed  CAS  Google Scholar 

  13. U. Schroeder and B. A. Sabel, Brain Res., 710, 121–124 (1996).

    Article  CAS  Google Scholar 

  14. U. Schroeder, P. Sommerfeld, and B. A. Sabel, Peptides, 19, 777–780 (1998).

    Article  PubMed  CAS  Google Scholar 

  15. U. Schroeder, P. Sommerfeld, S. Ulrich, and B. A. Sabel, J. harm. Sci., 87, 1305–1307 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. A. Shamenkov.

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 142, No. 12, pp. 659–662, December, 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shamenkov, D.A., Petrov, V.E. & Alyautdin, R.N. Effects of apolipoproteins on dalargin transport across the blood-brain barrier. Bull Exp Biol Med 142, 703–706 (2006). https://doi.org/10.1007/s10517-006-0456-x

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-006-0456-x

Key Words

Navigation